- Home
- FUSB vs XTNT Comparison
FUSB vs XTNT Comparison
Compare FUSB & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FUSB | XTNT |
|---|---|---|
| Founded | 1952 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.8M | 82.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FUSB | XTNT |
|---|---|---|
| Price | $13.53 | $0.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 9.3K | ★ 241.1K |
| Earning Date | 01-26-2026 | 11-10-2025 |
| Dividend Yield | ★ 2.05% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.93 | 0.01 |
| Revenue | $36,068,000.00 | ★ $133,083,000.00 |
| Revenue This Year | N/A | $15.08 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $14.71 | $69.41 |
| Revenue Growth | N/A | ★ 16.88 |
| 52 Week Low | $10.30 | $0.34 |
| 52 Week High | $14.79 | $0.95 |
Technical Indicators
Market Signals| Indicator | FUSB | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 49.66 | 58.53 |
| Support Level | $12.90 | $0.75 |
| Resistance Level | $13.71 | $0.83 |
| Average True Range (ATR) | 0.30 | 0.06 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 41.47 | 62.44 |
Price Performance
Historical ComparisonAbout FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.